Celularity Statistics

Total Valuation

Celularity has a market cap or net worth of $29.99 million. The enterprise value is $95.19 million.

Market Cap	29.99M
Enterprise Value	95.19M

Important Dates

The next estimated earnings date is Monday, May 11, 2026, before market open.

Earnings Date	May 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Celularity has 28.84 million shares outstanding. The number of shares has increased by 13.94% in one year.

Current Share Class	28.84M
Shares Outstanding	28.84M
Shares Change (YoY)	+13.94%
Shares Change (QoQ)	+9.69%
Owned by Insiders (%)	12.34%
Owned by Institutions (%)	13.32%
Float	18.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.70
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.16

Current Ratio	0.16
Quick Ratio	0.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.35

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-25.03%
Return on Invested Capital (ROIC)	-107.75%
Return on Capital Employed (ROCE)	-99.48%
Weighted Average Cost of Capital (WACC)	8.79%
Revenue Per Employee	$329,902
Profits Per Employee	-$655,667
Employee Count	123
Asset Turnover	0.33
Inventory Turnover	6.14

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.40% in the last 52 weeks. The beta is 0.71, so Celularity's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-35.40%
50-Day Moving Average	1.26
200-Day Moving Average	1.89
Relative Strength Index (RSI)	32.72
Average Volume (20 Days)	31,889

Short Selling Information

The latest short interest is 226,425, so 0.79% of the outstanding shares have been sold short.

Short Interest	226,425
Short Previous Month	294,642
Short % of Shares Out	0.79%
Short % of Float	1.21%
Short Ratio (days to cover)	6.98

Income Statement

In the last 12 months, Celularity had revenue of $40.58 million and -$80.65 million in losses. Loss per share was -$3.35.

Revenue	40.58M
Gross Profit	20.54M
Operating Income	-48.67M
Pretax Income	-80.65M
Net Income	-80.65M
EBITDA	-41.36M
EBIT	-48.67M
Loss Per Share	-$3.35

Full Income Statement

Balance Sheet

The company has $120,000 in cash and $66.76 million in debt, giving a net cash position of -$66.64 million or -$2.31 per share.

Cash & Cash Equivalents	120,000
Total Debt	66.76M
Net Cash	-66.64M
Net Cash Per Share	-$2.31
Equity (Book Value)	-20.09M
Book Value Per Share	-0.71
Working Capital	-54.72M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.56 million and capital expenditures -$91,000, giving a free cash flow of -$6.65 million.

Operating Cash Flow	-6.56M
Capital Expenditures	-91,000
Depreciation & Amortization	7.32M
Net Borrowing	16.39M
Free Cash Flow	-6.65M
FCF Per Share	-$0.23

Full Cash Flow Statement

Margins

Gross margin is 50.61%, with operating and profit margins of -119.95% and -198.75%.

Gross Margin	50.61%
Operating Margin	-119.95%
Pretax Margin	-198.75%
Profit Margin	-198.75%
EBITDA Margin	-101.91%
EBIT Margin	-119.95%
FCF Margin	n/a

Dividends & Yields

Celularity does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.94%
Shareholder Yield	-13.94%
Earnings Yield	-282.48%
FCF Yield	-23.29%

Analyst Forecast

The average price target for Celularity is $6.00, which is 476.92% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	476.92%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 29, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Feb 29, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

Celularity has an Altman Z-Score of -13.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-13.24
Piotroski F-Score	1